Software for Image-Based Medicine

MeVis BreastCare is a premier provider of innovative software applications for image-based screening, diagnosis and therapy of oncological diseases, in particular of the breast and liver. Our products are used by radiologists worldwide to turn data from all relevant imaging modalities into actionable clinical information.

JOINT-VENTURE

Our company was founded in 2001 as a joint-venture between MeVis Medical Solutions AG and Siemens Healthineers AG with the goal of commercializing our unique software prototype of a clinical image reading workstation for the emerging market of digital mammography. Building upon the commercial success of our first product we are continuously adding new products to our portfolio in order to broaden our footprint in breast imaging and to expand into new clinical imaging domains.

TRUSTED R&D PARTNER FOR HEALTHCARE MANUFACTURERS

In our close and long-standing relationships with our industry customers, we strive for excellence in all phases of the software life cycle. We offer our business partners high-quality R&D-related services including early product definition, programming and long-term maintenance plus support of clinical installations of our products.

KNOWING OUR SOFTWARE USERS AND THEIR CLINICAL WORK ENVIRONMENT - THAT'S US

It is our aim to improve the daily work of our software users as well as the quality of care for patients. That's why it is our ambition that every member of the MeVis BreastCare team has a thorough understanding of our users' clinical tasks, challenges, and of their clinical work environment and workflows. We consider this knowledge as the key to delivering products with outstanding usability, performance and reliability.

SOFTWARE EXPERTS - AGILE To THE CORE

With more than 10 years of experience in applying agile methodologies in medical device development, our dedication to agile principles is one of our core competencies for satisfying our customers’ demands for innovative and cost-effective software solutions, short time-to-market delivery and compliance with international regulatory requirements.